Angioedema, ACE inhibitor and COVID-19

SARS-CoV-2, the virus responsible for COVID-19, binds to the ACE2 receptors. ACE2 is thought to counterbalance ACE in the renin-angiotensin system. While presently it is advised that patients should continue to use ACE inhibitors or angiotensin receptor blockers, questions still remain as to whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Grewal, Ekjot, Sutarjono, Bayu, Mohammed, Ibbad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482445/
https://www.ncbi.nlm.nih.gov/pubmed/32912894
http://dx.doi.org/10.1136/bcr-2020-237888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482445/
https://www.ncbi.nlm.nih.gov/pubmed/32912894
http://dx.doi.org/10.1136/bcr-2020-237888

Ejemplares similares